Hémothorax cataménial : résultats de 11 cas opérés

R Ouede, Ouede R, Kone Z, Z. Koné, Z Kone, Landry Kohou-Koné, Kohou-Kone LL, L L Kohou-Kone, Kouacou MG, Maurice Gabin Kouacou, M G Kouacou, G Okon, Gérard Okon, Okon G, B A Demine, Demine BA, Blaise Demine, N'guessan E, E N'guessan, E. Nguessan, Kendja KF, K F Kendja, Yves Tanauh, Tanauh YR, Y R Tanauh
Revue des maladies respiratoires · 2022 · vol. 39(3) , pp. 221–227 · doi:10.1016/j.rmr.2021.12.009 · PMID:35219560 · W4213459017
article OA: closed CC0 ⤵ 2 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-07 ⓘ

This case series reports on 11 patients who underwent surgery for catamenial hemothorax, a rare condition involving recurrent blood in the pleural space associated with menstruation.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

ObjectiveTo report our therapeutic approach toward catamenial hemothorax.Patients and methodsThis retrospective study from January 1994 to November 2018 concerned patients operated under general anesthesia for catamenial hemothorax. A posterolateral thoracotomy approach was implemented either directly or after primary videothoracoscopy. Six-month hormone therapy was systematically prescribed postoperatively. The result was assessed in terms of occurrence or non-occurrence of hemothorax upon resumption of menses after discontinuation of hormone therapy.ResultsEleven patients were selected, with an average age was 32years (25-41). Catamenial hemothorax was associated with hemorrhagic ascites in 5 cases. Endometriotic plaques in the form of diaphragmatic fenestrations were found nine times and were resected (1 case) or covered by a synthetic non-absorbable patch (8 cases). Pleural symphysis completed the surgical procedures. The one hormone used was triptorelin. Mortality was zero. Mean postoperative hospital stay was 10.24days and mean follow-up was 3.5years. One patient was lost to follow-up at 3months. One hemothorax recurrence was observed after discontinuation of hormone therapy at 4months [1], and repeated pleural punctures were carried out while awaiting revision surgery. The five cases of ascites recurred and the patients were monitored in the gynecology unit.ConclusionIn patients suffering from catamenial hemothorax with diaphragmatic fenestrations, we recommend phrenoplasty using synthetic patches associated with pleural talcage and 6-month complementary concomitant hormone therapy.

My notes (saved in your browser only)

MeSH descriptors

Hemothorax Hemothorax Hemothorax Pneumothorax Pneumothorax Adult Ascites Ascites Female Hormones Humans Recurrence Retrospective Studies

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (33)

Cited by (2)

Source provenance

europepmc
last seen: 2026-07-29T06:27:48.050232+00:00
openalex
last seen: 2026-05-11T06:08:11.709964+00:00
pubmed
last seen: 2026-05-13T22:23:57.700195+00:00
License: CC0 · commercial use OK